Application for Approval of New Pancreatic Cancer Drug

*credit verbatim via Don Seiffert of Boston Business Journal*

Merrimack Pharmaceuticals plans to start submitting parts of its application for approval of its promising drug to treat pancreatic cancer before the end of the year after that drug earned fast-track designation from U.S. regulators.

(click above link to be taken to original article as it appeared)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s